Creative Biolabs actively engages in collaboration with biotech and pharmaceutical companies globally. Our proprietary platform addresses many of the shortcomings with existing methodologies. We aim at developing new approaches to the treatment of cancer and other serious diseases.

We offer fully integrated therapeutic drug discovery and engineering services to meet our customers’ specific requirements with our powerful NatAb™ platform. Our revolutionary drug discovery platform is fully different from hybridoma and phage display platforms, which are either limited by animal species, capacity or random VH-VL pairing. It enables sequencing of the paired heavy and light chain variable regions VH-VL repertoire form millions of single B cells within a few hours, resulting in antibodies selected for affinity, specificity, and functionality. More importantly, NatAb™ platform can be useful in variable systems for antibody discovery, such as human, mouse, chicken, canine, etc.

Learn More

To find out more about collaborating with Creative Biolabs, please contact us:

Please note: our NatAb™ platform can only provide services for research purposes. No clinical or therapeutic applications, please.